{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:54:07Z","timestamp":1794020047412,"version":"4.8.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.anai.2025.03.003","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:04:31Z","timestamp":1741626271000},"page":"649-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["What the clinician should know when ordering a mast cell tryptase test"],"prefix":"10.1016","volume":"134","author":[{"given":"Mo\u00efse","family":"Michel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Klingebiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bach-Nga","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-9408","authenticated-orcid":false,"given":"Joana","family":"Vitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0001","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0032-2016","article-title":"Paul Ehrlich and the early history of granulocytes","volume":"4","author":"Kay","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.anai.2025.03.003_bib0002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/164_2016_85","article-title":"Allergy, histamine and antihistamines","volume":"241","author":"Church","year":"2017","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0003","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-023-01493-2","article-title":"Slow integrin-dependent migration organizes networks of tissue-resident mast cells","volume":"24","author":"Kaltenbach","year":"2023","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0004","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.immuni.2020.01.012","article-title":"Human mast cell proteome reveals unique lineage, putative functions, and structural basis for cell ablation","volume":"52","author":"Plum","year":"2020","journal-title":"Immunity"},{"issue":"4S","key":"10.1016\/j.anai.2025.03.003_bib0005","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.jaci.2019.01.031","article-title":"Mast cells within cellular networks","volume":"144","author":"Stassen","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.03.003_bib0006","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2019.03.008","article-title":"Mast cell tryptase - Marker and maker of cardiovascular diseases","volume":"199","author":"Mohajeri","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.anai.2025.03.003_bib0007","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1002\/cpcb.52","article-title":"Isolation of human placental mast cells","volume":"80","author":"Mezouar","year":"2018","journal-title":"Curr Protoc Cell Biol"},{"issue":"23","key":"10.1016\/j.anai.2025.03.003_bib0008","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.7150\/thno.46719","article-title":"Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich's visions to precision medicine concepts","volume":"10","author":"Valent","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.anai.2025.03.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.12.017","article-title":"Directional mast cell degranulation of tumor necrosis factor into blood vessels primes neutrophil extravasation","volume":"54","author":"Dudeck","year":"2021","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0010","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jaci.2022.01.030","article-title":"Selected recent advances in understanding the role of human mast cells in health and disease","volume":"149","author":"Levi-Schaffer","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.03.003_bib0011","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/apm.13264","article-title":"Do mast cells contribute to the continued survival of vertebrates?","volume":"130","author":"Norrby","year":"2022","journal-title":"APMIS"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.04.025","article-title":"Hemogenic endothelial fate mapping reveals dual developmental origin of mast cells","volume":"48","author":"Gentek","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.anai.2025.03.003_bib0013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/imr.13191","article-title":"Mast cell ontogeny: from fetal development to life-long health and disease","volume":"315","author":"Chia","year":"2023","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.anai.2025.03.003_bib0014","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41577-022-00731-2","article-title":"New perspectives on the origins and heterogeneity of mast cells","volume":"23","author":"St John","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1084\/jem.2023057001172024c","article-title":"Correction: landscape of mast cell populations across organs in mice and humans","volume":"221","author":"Tauber","year":"2024","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.anai.2025.03.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230570","article-title":"Landscape of mast cell populations across organs in mice and humans","volume":"220","author":"Tauber","year":"2023","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.anai.2025.03.003_bib0017","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.138.8.2611","article-title":"Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells","volume":"138","author":"Schwartz","year":"1987","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0018","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2004.02.032","article-title":"Expression of alpha-tryptase and beta-tryptase by human basophils","volume":"113","author":"Jogie-Brahim","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0019","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s40629-020-00118-6","article-title":"Mast cells and IgE in defense against lethality of venoms: possible \u201cbenefit\u201d of allergy","volume":"29","author":"Galli","year":"2020","journal-title":"Allergo J Int"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/all.14852","article-title":"IgE antibodies increase honeybee venom responsiveness and detoxification efficiency of mast cells","volume":"77","author":"Starkl","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.08.002","article-title":"IgE effector mechanisms in concert with mast cells, contribute to acquired host defense against Staphylococcusaureus","volume":"53","author":"Starkl","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.anai.2025.03.003_bib0022","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3389\/fimmu.2018.01532","article-title":"Human mast cell tryptase is a potential treatment for snakebite envenoming across multiple snake species","volume":"9","author":"Anderson","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02669-18","article-title":"Mast cell cytonemes as a defense mechanism against Coxiella burnetii","volume":"10","author":"Mezouar","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.anai.2025.03.003_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.918305","article-title":"Mast cell and basophil granule proteases - in vivo targets and function","volume":"13","author":"Hellman","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaci.2016.11.044","article-title":"Tryptase-catalyzed core histone truncation: a novel epigenetic regulatory mechanism in mast cells","volume":"140","author":"Melo","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0026","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/ijms22052458","article-title":"Genetic regulation of tryptase production and clinical impact: hereditary alpha tryptasemia, mastocytosis and beyond","volume":"22","author":"Sprinzl","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0027","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000520972","article-title":"Mast cell tryptase potentiates neutrophil extracellular trap formation","volume":"14","author":"Pejler","year":"2022","journal-title":"J Innate Immun"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0028","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1085\/jgp.24.2.169","article-title":"Kinetics of thrombin inactivation as influenced by physical conditions, trypsin, and serum","volume":"24","author":"Glazko","year":"1940","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.anai.2025.03.003_bib0029","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/185846a0","article-title":"Histochemical demonstration of a species-specific trypsin-like enzyme in mast cells","volume":"185","author":"Glenner","year":"1960","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.anai.2025.03.003_bib0030","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.1016\/S0021-9258(19)68496-6","article-title":"Tryptase from human pulmonary mast cells. Purification and characterization","volume":"256","author":"Schwartz","year":"1981","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0031","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1172\/JCI114284","article-title":"Cloning and characterization of complementary DNA for human tryptase","volume":"84","author":"Miller","year":"1989","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.anai.2025.03.003_bib0032","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1172\/JCI114786","article-title":"Cloning and characterization of a second complementary DNA for human tryptase","volume":"86","author":"Miller","year":"1990","journal-title":"J Clin Invest"},{"issue":"26","key":"10.1016\/j.anai.2025.03.003_bib0033","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.anai.2025.03.003_bib0034","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.179.9.6072","article-title":"Mast cell alpha and beta tryptases changed rapidly during primate speciation and evolved from gamma-like transmembrane peptidases in ancestral vertebrates","volume":"179","author":"Trivedi","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrg727","article-title":"The complex structure and dynamic evolution of human subtelomeres","volume":"3","author":"Mefford","year":"2002","journal-title":"Nat Rev Genet"},{"issue":"2-4","key":"10.1016\/j.anai.2025.03.003_bib0036","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000024152","article-title":"Cloning of the human homolog of mouse transmembrane tryptase","volume":"118","author":"Wong","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.03.003_bib0037","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.4049\/jimmunol.169.9.5145","article-title":"Delta tryptase is expressed in multiple human tissues, and a recombinant form has proteolytic activity","volume":"169","author":"Wang","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.anai.2025.03.003_bib0038","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coi.2021.04.001","article-title":"Mast cell tryptases in allergic inflammation and immediate hypersensitivity","volume":"72","author":"Lyons","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2025.03.003_bib0039","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.4049\/jimmunol.164.12.6566","article-title":"Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families","volume":"164","author":"Caughey","year":"2000","journal-title":"J Immunol"},{"issue":"52","key":"10.1016\/j.anai.2025.03.003_bib0040","doi-asserted-by":"crossref","first-page":"49169","DOI":"10.1074\/jbc.M108677200","article-title":"Human tryptase epsilon (PRSS22), a new member of the chromosome 16p13.3 family of human serine proteases expressed in airway epithelial cells","volume":"276","author":"Wong","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0041","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/gim.2017.136","article-title":"A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number","volume":"20","author":"Lyons","year":"2018","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0042","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.anai.2021.06.019","article-title":"Inherited and acquired determinants of serum tryptase levels in humans","volume":"127","author":"Lyons","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.03.003_bib0043","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1365-2222.2002.01416.x","article-title":"Genetic deficiency of human mast cell alpha-tryptase","volume":"32","author":"Soto","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"9","key":"10.1016\/j.anai.2025.03.003_bib0044","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/bloodadvances.2022007936","article-title":"Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms","volume":"7","author":"Chovanec","year":"2023","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11882-024-01136-y","article-title":"Alpha-tryptase as a risk-modifying factor for mast cell-mediated reactions","volume":"24","author":"Shin","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"issue":"10","key":"10.1016\/j.anai.2025.03.003_bib0046","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2025.03.003_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.12.031","article-title":"Elevated basal serum tryptase: disease distribution and variability in a regional health system","volume":"10","author":"Waters","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.07.026","article-title":"Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations","volume":"124","author":"Trivedi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2025.03.003_bib0049","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.4049\/jimmunol.170.11.5667","article-title":"Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells","volume":"170","author":"Schwartz","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.anai.2022.08.996","article-title":"Tryptase in type I hypersensitivity","volume":"130","author":"Michel","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.03.003_bib0051","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"25","key":"10.1016\/j.anai.2025.03.003_bib0052","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1074\/jbc.M117.812016","article-title":"Dual functionality of beta-tryptase protomers as both proteases and cofactors in the active tetramer","volume":"293","author":"Maun","year":"2018","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.anai.2025.03.003_bib0053","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1074\/jbc.275.1.351","article-title":"Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases. Dependence on a conserved Trp-rich domain on the surface","volume":"275","author":"Huang","year":"2000","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.anai.2025.03.003_bib0054","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0056","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI114051","article-title":"Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis","volume":"83","author":"Schwartz","year":"1989","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.anai.2025.03.003_bib0057","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF01533368","article-title":"Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis","volume":"14","author":"Schwartz","year":"1994","journal-title":"J Clin Immunol"},{"issue":"16","key":"10.1016\/j.anai.2025.03.003_bib0058","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/S0021-9258(17)38401-6","article-title":"Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer","volume":"261","author":"Schwartz","year":"1986","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.anai.2025.03.003_bib0059","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1073\/pnas.96.20.10984","article-title":"The structure of the human betaII-tryptase tetramer: fo(u)r better or worse","volume":"96","author":"Sommerhoff","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.anai.2025.03.003_bib0060","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.4049\/jimmunol.160.9.4561","article-title":"Regulation of human mast cell beta-tryptase: conversion of inactive monomer to active tetramer at acid pH","volume":"160","author":"Ren","year":"1998","journal-title":"J Immunol"},{"issue":"33","key":"10.1016\/j.anai.2025.03.003_bib0061","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1021\/bi049486c","article-title":"Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors","volume":"43","author":"Fukuoka","year":"2004","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0062","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis","volume":"96","author":"Schwartz","year":"1995","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0063","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.4049\/jimmunol.176.5.3165","article-title":"The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized beta-tryptase to form monomers that are inactive at neutral pH and active at acidic pH","volume":"176","author":"Fukuoka","year":"2006","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.anai.2025.03.003_bib0064","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.jaip.2021.03.011","article-title":"Use and interpretation of acute and baseline tryptase in perioperative hypersensitivity and anaphylaxis","volume":"9","author":"Vitte","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2025.03.003_bib0065","first-page":"329","article-title":"Performance criteria for the verification of IgE and tryptase assay methods: recommendations from the AllergoBioNet network","volume":"78","author":"Sarrat","year":"2020","journal-title":"Ann Biol Clin"},{"issue":"12","key":"10.1016\/j.anai.2025.03.003_bib0066","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.anai.2025.03.003_bib0067","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.jaip.2022.05.003","article-title":"Incorporating tryptase genotyping into the workup and diagnosis of mast cell diseases and reactions","volume":"10","author":"Lyons","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2025.03.003_bib0068","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41598-024-52983-8","article-title":"Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping","volume":"14","author":"Svetina","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.anai.2025.03.003_bib0069","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jaip.2023.08.008","article-title":"The normal range of baseline tryptase should be 1 to 15 ng\/mL and covers healthy individuals with HalphaT","volume":"11","author":"Valent","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.iac.2023.04.008","article-title":"KIT mutations and other genetic defects in mastocytosis: implications for disease pathology and targeted therapies","volume":"43","author":"Chantran","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0071","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2025.03.003_bib0072","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/bloodadvances.2022007936","article-title":"Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms","volume":"7","author":"Chovanec","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.anai.2025.03.003_bib0073","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jaci.2022.11.017","article-title":"HalphaT is associated with increased risk for severe Hymenoptera venom-triggered anaphylaxis","volume":"151","author":"Selb","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0074","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/ACI.0000000000000813","article-title":"Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker","volume":"22","author":"O'Connell","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0075","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.anai.2022.07.025","article-title":"Temporal variation of tryptase and interlaboratory variability","volume":"129","author":"Ritter","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0076","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1515\/cclm-2023-0606","article-title":"Short-term biological variation of serum tryptase","volume":"62","author":"Madsen","year":"2024","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"10.1016\/j.anai.2025.03.003_bib0077","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1111\/all.15369","article-title":"Tryptase reference ranges are age-dependent in a large population-based cohort","volume":"77","author":"Slot","year":"2022","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.anai.2025.03.003_bib0078","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/cea.14195","article-title":"Tryptase reference values in a Swedish middle-aged general population and association with diabetes mellitus","volume":"52","author":"Vitte","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"10.1016\/j.anai.2025.03.003_bib0079","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1111\/all.15790","article-title":"Basal serum tryptase: a critical reconsideration of reference values","volume":"78","author":"Francois","year":"2023","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0080","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/acer.12682","article-title":"Serum concentrations of mast cell tryptase are reduced in heavy drinkers","volume":"39","author":"Beceiro","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0081","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1399-3038.2011.01166.x","article-title":"Total serum tryptase levels are higher in young infants","volume":"22","author":"Belhocine","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"12","key":"10.1016\/j.anai.2025.03.003_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2024.08.044","article-title":"Harmonization of diagnostic criteria in mastocytosis for use in clinical practice: WHO vs ICC vs AIM\/ECNM","volume":"12","author":"Valent","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0083","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3390\/ijms22052586","article-title":"Molecular background, clinical features and management of pediatric mastocytosis: status 2021","volume":"22","author":"Lange","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.anai.2025.03.003_bib0084","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/ijms22010411","article-title":"Clinical impact of inherited and acquired genetic variants in mastocytosis","volume":"22","author":"Nedoszytko","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.anai.2025.03.003_bib0085","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0086","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/cea.14264","article-title":"Clonal mast cell disorders and hereditary alpha-tryptasemia as risk factors for anaphylaxis","volume":"53","author":"Kacar","year":"2023","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.09.038","article-title":"Disease correlates and clinical relevance of hereditary alpha-tryptasemia in patients with systemic mastocytosis","volume":"151","author":"Sordi","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0088","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.anai.2021.08.009","article-title":"Clinical relevance of inherited genetic differences in human tryptases: hereditary alpha-tryptasemia and beyond","volume":"127","author":"Glover","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0089","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0090","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2023.07.014","article-title":"Severe food allergy reactions are associated with alpha-tryptase","volume":"152","author":"Lang","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0091","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.03.003_bib0092","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.jaip.2024.03.010","article-title":"Detecting changes in mast cell numbers versus activation in human disease: a roadblock for current biomarkers?","volume":"12","author":"Akin","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2025.03.003_bib0093","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1182\/bloodadvances.2024012756","article-title":"Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM","volume":"8","author":"Lubke","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.anai.2025.03.003_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11882-021-01010-1","article-title":"Hereditary alpha-tryptasemia: a commonly inherited modifier of anaphylaxis","volume":"21","author":"Wu","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2025.03.003_bib0096","article-title":"Case Report: A family history of peanut allergy and hereditary alpha-tryptasemia","volume":"4","author":"Chantran","year":"2023","journal-title":"Front Allergy"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0097","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/all.16284","article-title":"Higher levels of basal serum tryptase are associated with sensitization, FeNO, allergic morbidity, and lower control of allergic asthma in teenagers from the Paris birth cohort","volume":"80","author":"Chantran","year":"2025","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0099","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2025.03.003_bib0100","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","article-title":"Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia","volume":"98","author":"Sperr","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.anai.2025.03.003_bib0101","doi-asserted-by":"crossref","first-page":"e13000","DOI":"10.1111\/eci.13000","article-title":"The underestimated role of basophils in Ph(+) chronic myeloid leukaemia","volume":"48","author":"Valent","year":"2018","journal-title":"Eur J Clin Investig"},{"issue":"12","key":"10.1016\/j.anai.2025.03.003_bib0102","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neo.2021.09.010","article-title":"Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis","volume":"23","author":"Berger","year":"2021","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.anai.2025.03.003_bib0103","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2025.03.003_bib0104","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11882-024-01124-2","article-title":"Reversible elevation of tryptase over the individual's baseline: why is it the best biomarker for severe systemic mast cell activation and MCAS?","volume":"24","author":"Valent","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0105","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/all.13752","article-title":"Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: an observational study","volume":"74","author":"Vitte","year":"2019","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2018.01.006","article-title":"Diagnostic value of tryptase in food allergic reactions: A prospective study of 160 adult peanut challenges","volume":"6","author":"Dua","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2025.03.003_bib0107","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/ALN.0000000000000584","article-title":"Presence or absence of elevated acute total serum tryptase by itself is not a definitive marker for an allergic reaction","volume":"122","author":"Sprung","year":"2015","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.anai.2025.03.003_bib0108","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/all.13820","article-title":"An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions","volume":"74","author":"Garvey","year":"2019","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0109","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/ACI.0000000000001012","article-title":"Tryptase in drug-induced anaphylaxis: the need for acute and baseline values","volume":"24","author":"Michel","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2025.03.003_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.03.050","article-title":"Mast cell activation during suspected perioperative hypersensitivity: a need for paired samples analysis","volume":"9","author":"Ebo","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2025.03.003_bib0111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.03.003_bib0112","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000501079","article-title":"Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome","volume":"180","author":"Valent","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.03.003_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.03.003_bib0114","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jaci.2015.09.001","article-title":"Tryptase levels in children presenting with anaphylaxis: temporal trends and associated factors","volume":"137","author":"De Schryver","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.03.003_bib0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cea.14110","article-title":"Tryptase release does not discriminate between IgE- and MRGPRX2-mediated activation in human mast cells","volume":"52","author":"Elst","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2025.03.003_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjao.2023.100254","article-title":"Paediatric perioperative hypersensitivity: the performance of the current consensus formula and the effect of uneventful anaesthesia on serum tryptase","volume":"9","author":"Vlaeminck","year":"2024","journal-title":"BJA Open"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0117","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/ACI.0000000000000768","article-title":"Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review","volume":"21","author":"Sabato","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol."},{"issue":"11","key":"10.1016\/j.anai.2025.03.003_bib0118","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/cea.14406","article-title":"Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids","volume":"53","author":"Bauer","year":"2023","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"10.1016\/j.anai.2025.03.003_bib0119","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.jaip.2022.03.008","article-title":"Nontryptase urinary and hematologic biomarkers of mast cell expansion and mast cell activation: status 2022","volume":"10","author":"Butterfield","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2025.03.003_bib0120","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jaci.2022.04.025","article-title":"Castells M. Differential mast cell mediators in systemic mastocytosis and hereditary alpha-tryptasemia","volume":"150","author":"Giannetti","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2025.03.003_bib0121","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jaip.2023.02.017","article-title":"Increased excretion of mast cell mediator metabolites during mast cell activation syndrome","volume":"11","author":"Butterfield","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8045","key":"10.1016\/j.anai.2025.03.003_bib0122","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-024-08264-5","article-title":"Haematological setpoints are a stable and patient-specific deep phenotype","volume":"637","author":"Foy","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.anai.2025.03.003_bib0123","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1483398","article-title":"In vitro diagnosis of allergic and mast cell-mediated disorders","volume":"5","author":"Vitte","year":"2024","journal-title":"Front Allergy"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T09:15:41Z","timestamp":1748855741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1081120625001206"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.03.003","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What the clinician should know when ordering a mast cell tryptase test","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}